vs
Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and LandBridge Co LLC (LB). Click either name above to swap in a different company.
LandBridge Co LLC is the larger business by last-quarter revenue ($51.0M vs $47.7M, roughly 1.1× IRONWOOD PHARMACEUTICALS INC). LandBridge Co LLC runs the higher net margin — 35.0% vs -4.8%, a 39.8% gap on every dollar of revenue. On growth, LandBridge Co LLC posted the faster year-over-year revenue change (16.0% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $40.9M). Over the past eight quarters, LandBridge Co LLC's revenue compounded faster (40.2% CAGR vs -20.2%).
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
IRWD vs LB — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $47.7M | $51.0M |
| Net Profit | $-2.3M | $17.9M |
| Gross Margin | — | — |
| Operating Margin | 14.3% | 57.2% |
| Net Margin | -4.8% | 35.0% |
| Revenue YoY | -47.3% | 16.0% |
| Net Profit YoY | -200.9% | 15.6% |
| EPS (diluted) | $0.01 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $51.0M | ||
| Q4 25 | $47.7M | $56.8M | ||
| Q3 25 | $122.1M | $50.8M | ||
| Q2 25 | $85.2M | $47.5M | ||
| Q1 25 | $41.1M | $44.0M | ||
| Q4 24 | $90.5M | $36.5M | ||
| Q3 24 | $91.6M | $28.5M | ||
| Q2 24 | $94.4M | $26.0M |
| Q1 26 | — | $17.9M | ||
| Q4 25 | $-2.3M | $8.1M | ||
| Q3 25 | $40.1M | $8.1M | ||
| Q2 25 | $23.6M | $7.5M | ||
| Q1 25 | $-37.4M | $6.5M | ||
| Q4 24 | $2.3M | $49.3M | ||
| Q3 24 | $3.6M | $2.7M | ||
| Q2 24 | $-860.0K | $-57.7M |
| Q1 26 | — | 57.2% | ||
| Q4 25 | 14.3% | 60.0% | ||
| Q3 25 | 61.8% | 60.8% | ||
| Q2 25 | 53.2% | 60.0% | ||
| Q1 25 | -70.7% | 57.0% | ||
| Q4 24 | 34.8% | 49.4% | ||
| Q3 24 | 28.0% | 11.2% | ||
| Q2 24 | 26.5% | -197.4% |
| Q1 26 | — | 35.0% | ||
| Q4 25 | -4.8% | 14.2% | ||
| Q3 25 | 32.8% | 15.9% | ||
| Q2 25 | 27.7% | 15.8% | ||
| Q1 25 | -90.9% | 14.7% | ||
| Q4 24 | 2.5% | 135.2% | ||
| Q3 24 | 4.0% | 9.3% | ||
| Q2 24 | -0.9% | -222.1% |
| Q1 26 | — | — | ||
| Q4 25 | $0.01 | $0.24 | ||
| Q3 25 | $0.23 | $0.26 | ||
| Q2 25 | $0.14 | $0.24 | ||
| Q1 25 | $-0.23 | $0.20 | ||
| Q4 24 | $0.03 | — | ||
| Q3 24 | $0.02 | $-0.04 | ||
| Q2 24 | $-0.01 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $215.5M | $29.7M |
| Total DebtLower is stronger | — | $433.0K |
| Stockholders' EquityBook value | $-261.8M | — |
| Total Assets | $396.9M | $1.4B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $29.7M | ||
| Q4 25 | $215.5M | $30.7M | ||
| Q3 25 | $140.4M | $28.3M | ||
| Q2 25 | $92.9M | $20.3M | ||
| Q1 25 | $108.5M | $14.9M | ||
| Q4 24 | $88.6M | $37.0M | ||
| Q3 24 | $88.2M | $14.4M | ||
| Q2 24 | $105.5M | $24.6M |
| Q1 26 | — | $433.0K | ||
| Q4 25 | — | $570.7M | ||
| Q3 25 | $199.5M | $366.1M | ||
| Q2 25 | $199.3M | $370.9M | ||
| Q1 25 | $199.2M | $375.5M | ||
| Q4 24 | $199.0M | $385.5M | ||
| Q3 24 | $198.8M | $242.4M | ||
| Q2 24 | $198.6M | $360.8M |
| Q1 26 | — | — | ||
| Q4 25 | $-261.8M | $340.3M | ||
| Q3 25 | $-264.2M | $272.0M | ||
| Q2 25 | $-308.2M | $266.4M | ||
| Q1 25 | $-334.1M | $217.0M | ||
| Q4 24 | $-301.3M | $211.8M | ||
| Q3 24 | $-311.3M | $97.2M | ||
| Q2 24 | $-321.7M | $296.4M |
| Q1 26 | — | $1.4B | ||
| Q4 25 | $396.9M | $1.4B | ||
| Q3 25 | $396.1M | $1.1B | ||
| Q2 25 | $342.9M | $1.1B | ||
| Q1 25 | $327.2M | $1.0B | ||
| Q4 24 | $350.9M | $1.0B | ||
| Q3 24 | $389.5M | $689.9M | ||
| Q2 24 | $395.6M | $710.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.68× | ||
| Q3 25 | — | 1.35× | ||
| Q2 25 | — | 1.39× | ||
| Q1 25 | — | 1.73× | ||
| Q4 24 | — | 1.82× | ||
| Q3 24 | — | 2.49× | ||
| Q2 24 | — | 1.22× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $74.6M | $41.1M |
| Free Cash FlowOCF − Capex | $74.6M | $40.9M |
| FCF MarginFCF / Revenue | 156.3% | 80.3% |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | 2.30× |
| TTM Free Cash FlowTrailing 4 quarters | $127.0M | $232.8M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $41.1M | ||
| Q4 25 | $74.6M | $126.3M | ||
| Q3 25 | $47.6M | $34.9M | ||
| Q2 25 | $-15.1M | $37.3M | ||
| Q1 25 | $20.0M | $15.9M | ||
| Q4 24 | $15.2M | $67.6M | ||
| Q3 24 | $9.9M | $7.5M | ||
| Q2 24 | $33.5M | $16.0M |
| Q1 26 | — | $40.9M | ||
| Q4 25 | $74.6M | $122.0M | ||
| Q3 25 | $47.6M | $33.7M | ||
| Q2 25 | $-15.1M | $36.1M | ||
| Q1 25 | $19.9M | $15.8M | ||
| Q4 24 | — | $66.7M | ||
| Q3 24 | $9.9M | $7.1M | ||
| Q2 24 | $33.4M | $15.7M |
| Q1 26 | — | 80.3% | ||
| Q4 25 | 156.3% | 214.9% | ||
| Q3 25 | 39.0% | 66.3% | ||
| Q2 25 | -17.7% | 75.9% | ||
| Q1 25 | 48.4% | 36.0% | ||
| Q4 24 | — | 182.6% | ||
| Q3 24 | 10.8% | 25.1% | ||
| Q2 24 | 35.4% | 60.4% |
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | 7.5% | ||
| Q3 25 | 0.0% | 2.3% | ||
| Q2 25 | 0.0% | 2.6% | ||
| Q1 25 | 0.1% | 0.2% | ||
| Q4 24 | 0.0% | 2.7% | ||
| Q3 24 | 0.0% | 1.1% | ||
| Q2 24 | 0.1% | 1.4% |
| Q1 26 | — | 2.30× | ||
| Q4 25 | — | 15.68× | ||
| Q3 25 | 1.19× | 4.31× | ||
| Q2 25 | -0.64× | 4.98× | ||
| Q1 25 | — | 2.46× | ||
| Q4 24 | 6.74× | 1.37× | ||
| Q3 24 | 2.71× | 2.80× | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IRWD
Segment breakdown not available.
LB
| Other | $14.2M | 28% |
| Easements and other surface-related revenues | $11.6M | 23% |
| Surface use royalties - related party | $11.0M | 22% |
| Resource sales | $5.2M | 10% |
| Resource royalties | $4.3M | 8% |
| Easements and other surface-related revenues - related party | $3.2M | 6% |
| Resource royalties - related party | $1.3M | 2% |
| Resource sales - related party | $205.0K | 0% |
